CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 198 shares at $28.54 ($5,651)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Trachtenberg Eric sold 194 shares at $6.52 ($1,265)
- 4 Open-market sale Bazemore Todd sold 214 shares at $6.51 ($1,393)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 194 shares at $6.51 ($1,263)
- 4 Open-market sale Brazzell Romulus K sold 261 shares at $6.51 ($1,699)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 561 shares at $6.52 ($3,658)
- 4 Open-market sale Trachtenberg Eric sold 2,613 shares at $0.37 ($967)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 2,613 shares at $0.37 ($967)
- 4 Open-market sale Brazzell Romulus K sold 3,144 shares at $0.37 ($1,163)
- 4 Open-market sale Bazemore Todd sold 3,092 shares at $0.37 ($1,144)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 7,975 shares at $0.37 ($2,951)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 1,005,686 shares at $0.36 ($365,667)
Page 6 of 15 · 288 filings